Milestone Pharmaceutiques IncNovember 19, 2024

FDA 483 - Milestone Pharmaceutiques Inc - November 19, 2024

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

Milestone Pharmaceuticals Inc. in Saint-Laurent was inspected by the FDA from November 11-19, 2024. The inspection identified a failure by the firm to notify the FDA about the for-cause termination of a clinical investigator from a study. This observation highlights a lapse in regulatory reporting requirements for clinical trials.

Company: Milestone Pharmaceutiques Inc
Inspection Date: November 19, 2024
Product Type: Drugs
Office: Office of Inspections and Investigations
Person: David L. Chon (Consumer Safety Officer/BIMO Investigator)

Open in Dashboard

ID · 14b2ec40-b625-45cb-99a3-051369423430